Gilead Sciences | 대출 자본



Loan Capital 변화 날짜
AbbVie USD 60.34B 1.83B 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
ALKERMES USD 0 285.82M 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Biogen USD 4.55B 1.4M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Bristol-Myers Squibb USD 46.16B 1.45B 2025-03
Eli Lilly USD 34.5B 5.97B 2025-03
Gilead Sciences USD 24.9B 3.46B 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
Glaxosmithkline GBP 14.64B 1.39B 2024-12
Incyte USD 32.64M 899K 2025-03
J&J USD 38.36B 7.7B 2025-03
Merck USD 34.46B 520M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
Pfizer USD 57.4B 597M 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Sanofi 13.41B 1.62B 2025-03
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
United Therapeutics USD 0 0 2025-03
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Gilead Sciences 대출 자본 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.